Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICS

LaFon DC, Woo H, Fedarko N, Azar A, Hill H, Tebo AE, Martins TB, Han MK, Krishnan JA, Ortega VE, Barjaktarevic I, Kaner RJ, Hastie A, O'Neal WK, Couper D, Woodruff PG, Curtis JL, Hansel NN, Nahm MH, Dransfield MT, Putcha N; SPIROMICS investigators. Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICS. Clin Immunol. 2023 Apr 6:109324. doi: 10.1016/j.clim.2023.109324. Epub ahead of print. PMID: 37030524.


Related Posts